7Baggers
 tg therapeutics ranks 27th on deloitte's technology fast 500 for 2025  Quiver Quantitative Wed, 19 Nov 2025 13:46:00 GMT
 tg therapeutics at td cowen summit: strategic insights on briumvi by investing.com  Investing.com Nigeria Thu, 13 Nov 2025 05:31:15 GMT
 Roche Rival Plunges On 'Unprecedented' Results In MS Treatment  Investor's Business Daily Mon, 10 Nov 2025 08:00:00 GMT
 Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight  GuruFocus Thu, 06 Nov 2025 05:21:45 GMT
 tg therapeutics reports strong q3 2025 results  MSN Wed, 05 Nov 2025 21:56:27 GMT
 why tg therapeutics (tgtx) is a top growth stock for the long-term  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 tgtx's q3 earnings & revenues trump estimates, 2025 view raised  TradingView Tue, 04 Nov 2025 15:26:00 GMT
 tg therapeutics: q3 earnings snapshot  theheraldreview.com Tue, 04 Nov 2025 11:16:31 GMT
 hc wainwright predicts reduced earnings for tg therapeutics  MarketBeat Tue, 04 Nov 2025 11:05:22 GMT
 TG Therapeutics Earns Membership In 95-Plus Composite Rating Club  Investor's Business Daily Tue, 04 Nov 2025 08:00:00 GMT
 TG Therapeutics Reports Strong Q3 2025 Results  The Globe and Mail Tue, 04 Nov 2025 08:00:00 GMT
 tg therapeutics, inc. (nasdaq:tgtx) q3 2025 earnings call transcript  Insider Monkey Tue, 04 Nov 2025 08:00:00 GMT
 tg therapeutics, inc. raises earnings guidance for the year 2025  MarketScreener Mon, 03 Nov 2025 20:07:39 GMT
 transcript : tg therapeutics, inc., q3 2025 earnings call, nov 03, 2025  MarketScreener Mon, 03 Nov 2025 16:50:21 GMT
 tg therapeutics q3 2025 earnings call transcript  MarketBeat Mon, 03 Nov 2025 14:37:30 GMT
 tg therapeutics inc (tgtx) reports q3 2025 revenue of $161.7 mil  GuruFocus Mon, 03 Nov 2025 12:56:01 GMT
 tg therapeutics (tgtx) increases 2025 briumvi revenue forecast  GuruFocus Mon, 03 Nov 2025 12:53:04 GMT
 tg therapeutics reports q3 eps $2.43, consensus 22c  TipRanks Mon, 03 Nov 2025 12:47:20 GMT
 tg therapeutics (tgtx) surpasses q3 revenue expectations and exp  GuruFocus Mon, 03 Nov 2025 12:45:00 GMT

TG Therapeutics, Inc
(NASDAQ:TGTX) 

TGTX stock logo

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclon...

Founded: 1993
Full Time Employees: 217
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends